Temat: "Bromocriptine" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
Autorzy :: Aguayo-Cerón KA; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Calzada-Mendoza CC; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Méndez-Bolaina E; Facultad de Ciencias Químicas, Universidad Veracruzana , Veracruz, México.
Romero-Nava R; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.; Departamento de Farmacología, Hospital Infantil de México Federico Gómez (HIMFG) , México City, México.
Ocharan-Hernández ME; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.; Pokaż więcej
Źródło :: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2020 Oct 02; Vol. 42 (7), pp. 675-679. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji :: Journal Article
MeSH Terms :: Bromocriptine/*pharmacology
Cardiomegaly/*metabolism
Dopamine Agonists/*pharmacology
Myocardium/*metabolism
Receptors, Dopamine D2/*metabolism
Receptors, Prolactin/*metabolism
Animals ; Bromocriptine/metabolism ; Bromocriptine/therapeutic use ; Cardiomegaly/prevention & control ; Male ; Rats ; Receptors, Dopamine D2/agonists
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Bromocriptine Nanoemulsion-Loaded Transdermal Gel: Optimization Using Factorial Design, In Vitro and In Vivo Evaluation.
Autorzy :: Sita V G; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University under Section 3 of UGC Act 1956, Elite Status and Center of Excellence-Govt. of Maharashtra, N. P. Marg, Matunga (E), Mumbai, 400019, India.
Vavia P; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University under Section 3 of UGC Act 1956, Elite Status and Center of Excellence-Govt. of Maharashtra, N. P. Marg, Matunga (E), Mumbai, 400019, India. .; Pokaż więcej
Źródło :: AAPS PharmSciTech [AAPS PharmSciTech] 2020 Jan 23; Vol. 21 (3), pp. 80. Date of Electronic Publication: 2020 Jan 23.
Typ publikacji :: Journal Article
MeSH Terms :: Bromocriptine/*administration & dosage
Administration, Cutaneous ; Animals ; Bromocriptine/chemistry ; Bromocriptine/pharmacokinetics ; Emulsions/administration & dosage ; Gels/chemistry ; Male ; Nanotechnology ; Rats ; Rats, Wistar ; Skin/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
Autorzy :: Sheikhpour M; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.
Sadeghizadeh M; Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Yazdian F; Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Mansoori A; Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.
Asadi H; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.
Movafagh A; Department of Medical Genetics, Cancer Research Center, Shohada Hospital School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Shahraeini SS; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.; Pokaż więcej
Źródło :: Iranian biomedical journal [Iran Biomed J] 2020 Jan; Vol. 24 (1), pp. 24-9. Date of Electronic Publication: 2019 Aug 28.
Typ publikacji :: Journal Article
MeSH Terms :: Apoptosis*/drug effects
Drug Delivery Systems*
Bromocriptine/*administration & dosage
Bromocriptine/*therapeutic use
Curcumin/*administration & dosage
Curcumin/*therapeutic use
Lung Neoplasms/*drug therapy
Nanoparticles/*chemistry
Bromocriptine/pharmacology ; Cell Line, Tumor ; Cell Survival/drug effects ; Curcumin/pharmacology ; Drug Liberation ; Humans ; Liposomes ; Lung Neoplasms/pathology ; Particle Size
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane.
Autorzy :: Yin J; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Chen KM; Institute of Bioengineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Clark MJ; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA.
Hijazi M; Institute of Bioengineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Kumari P; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bai XC; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sunahara RK; Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, USA. .
Barth P; Institute of Bioengineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland. .
Rosenbaum DM; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA. .; Pokaż więcej
Źródło :: Nature [Nature] 2020 Aug; Vol. 584 (7819), pp. 125-129. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Cryoelectron Microscopy*
Membranes, Artificial*
GTP-Binding Protein alpha Subunits, Gi-Go/*chemistry
GTP-Binding Protein alpha Subunits, Gi-Go/*ultrastructure
Membrane Lipids/*metabolism
Receptors, Dopamine D2/*chemistry
Receptors, Dopamine D2/*ultrastructure
Bromocriptine/chemistry ; Bromocriptine/metabolism ; Dopamine/chemistry ; Dopamine/metabolism ; GTP-Binding Protein alpha Subunits, Gi-Go/metabolism ; Humans ; Membrane Lipids/chemistry ; Models, Molecular ; Protein Conformation ; Receptors, Dopamine D2/agonists ; Receptors, Dopamine D2/metabolism ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: [Bromocriptine in disorders of consciouness due to traumatic brain injury].
Autorzy :: Otero Villaverde S; Complexo Hospitalario Universitario A Coruña, La Coruña, España. Electronic address: .
Martin Mourelle R; Complexo Hospitalario Universitario A Coruña, La Coruña, España.
Crespo Lopez C; Complexo Hospitalario Universitario A Coruña, La Coruña, España.
Cabrera Sarmiento JJ; Complexo Hospitalario Universitario A Coruña, La Coruña, España.
Ruiz Castillo A; Complexo Hospitalario Universitario A Coruña, La Coruña, España.
Canosa Hermida E; Complexo Hospitalario Universitario A Coruña, La Coruña, España.; Pokaż więcej
Transliterated Title :: Uso de bromocriptina en pacientes con alteración de conciencia secundaria a traumatismo craneoencefálico.
Źródło :: Rehabilitacion [Rehabilitacion (Madr)] 2019 Jul - Sep; Vol. 53 (3), pp. 155-161. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji :: Journal Article
MeSH Terms :: Brain Injuries, Traumatic/*complications
Bromocriptine/*therapeutic use
Central Nervous System Agents/*therapeutic use
Consciousness Disorders/*drug therapy
Adolescent ; Adult ; Bromocriptine/administration & dosage ; Central Nervous System Agents/administration & dosage ; Coma, Post-Head Injury/drug therapy ; Drug Administration Schedule ; Humans ; Middle Aged ; Persistent Vegetative State/drug therapy ; Retrospective Studies ; Risk Assessment ; Trauma Severity Indices ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Pharmacological interventions for antisocial personality disorder.
Autorzy :: Khalifa NR; Department of Psychiatry, Queen's University, Kingston, Canada.
Gibbon S; Arnold Lodge, Nottinghamshire Healthcare NHS Foundation Trust, Leicester, UK.
Völlm BA; Department of Forensic Psychiatry, Center for Neurology, University Rostock, Rostock, Germany.
Cheung NH; Forensic Research, Nottinghamshire Healthcare NHS Foundation Trust, Leicester, UK.
McCarthy L; Arnold Lodge, Nottinghamshire Healthcare NHS Foundation Trust, Leicester, UK.; Pokaż więcej
Źródło :: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Sep 03; Vol. 9. Cochrane AN: CD007667. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :: Antisocial Personality Disorder/*drug therapy
Psychotropic Drugs/*therapeutic use
Adult ; Aggression/drug effects ; Alcohol-Related Disorders/drug therapy ; Amantadine/therapeutic use ; Anxiety/drug therapy ; Bromocriptine/therapeutic use ; Desipramine/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Nortriptyline/therapeutic use ; Phenytoin/therapeutic use ; Placebos/therapeutic use ; Randomized Controlled Trials as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Neuroleptic malignant syndrome in a COVID-19 patient.
Autorzy :: Kajani R; Adventist Health White Memorial, Los Angeles, CA, United States.
Apramian A; Adventist Health White Memorial, Los Angeles, CA, United States.
Vega A; Adventist Health White Memorial, Los Angeles, CA, United States.
Ubhayakar N; Adventist Health White Memorial, Los Angeles, CA, United States.
Xu P; Adventist Health White Memorial, Los Angeles, CA, United States.
Liu A; Adventist Health White Memorial, Los Angeles, CA, United States.; Pokaż więcej
Źródło :: Brain, behavior, and immunity [Brain Behav Immun] 2020 Aug; Vol. 88, pp. 28-29. Date of Electronic Publication: 2020 May 18.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Antipsychotic Agents/*adverse effects
Coronavirus Infections/*complications
Haloperidol/*analogs & derivatives
Neuroleptic Malignant Syndrome/*etiology
Pneumonia, Viral/*complications
Schizophrenia/*drug therapy
Acute Kidney Injury/etiology ; Acute Kidney Injury/therapy ; Betacoronavirus ; Bromocriptine/therapeutic use ; C-Reactive Protein/immunology ; COVID-19 ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Dantrolene/therapeutic use ; Dopamine Agonists/therapeutic use ; Enzyme Inhibitors/therapeutic use ; Haloperidol/adverse effects ; Humans ; Hydroxychloroquine/therapeutic use ; Intensive Care Units ; Leukocytosis ; Lymphopenia ; Male ; Middle Aged ; Muscle Relaxants, Central/therapeutic use ; Neuroleptic Malignant Syndrome/physiopathology ; Neuroleptic Malignant Syndrome/therapy ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; Renal Dialysis ; Respiration, Artificial ; Rhabdomyolysis/etiology ; Rhabdomyolysis/therapy ; SARS-CoV-2 ; Schizophrenia/complications
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells.
Autorzy :: Zhang SL; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .
Tang HB; Department of Laboratory Medicine, Xi'an Central Hospital, Xi'an Jiaotong University, 161 Xi Wu Road, Xi'an, Shaanxi, 710003, China. Electronic address: .
Hu JT; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .
Zang ZL; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .
Ding X; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .
Li S; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .
Yang H; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183th Street of Shapingba District, Chongqing, 400037, China. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2019 Mar; Vol. 111, pp. 638-648. Date of Electronic Publication: 2019 Jan 03.
Typ publikacji :: Journal Article
MeSH Terms :: Bromocriptine/*pharmacology
Cyclophilins/*metabolism
Mitochondrial Proteins/*metabolism
Phosphoprotein Phosphatases/*metabolism
Prolactinoma/*metabolism
Protein Kinases/*metabolism
Receptor-Interacting Protein Serine-Threonine Kinases/*metabolism
Adolescent ; Adult ; Aged ; Animals ; Apoptosis/drug effects ; Apoptosis/physiology ; Bromocriptine/therapeutic use ; Cell Survival ; Dopamine Agonists/pharmacology ; Dopamine Agonists/therapeutic use ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Middle Aged ; Necrosis/drug therapy ; Necrosis/metabolism ; Necrosis/pathology ; Prolactinoma/drug therapy ; Prolactinoma/pathology ; Rats ; Signal Transduction/drug effects ; Signal Transduction/physiology ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
Autorzy :: O'Sullivan SM; Pharmacology, University of Auckland, Auckland, New Zealand.; Endocrinology, Fertility Associates, Ascot Hospital, Auckland, New Zealand.
Farrant MT; Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.
Ogilvie CM; Endocrinology, Fertility Associates, Ascot Hospital, Auckland, New Zealand.; Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.
Gunn AJ; Physiology, University of Auckland, Auckland, New Zealand.; Paediatrics, University of Auckland, Auckland, New Zealand.
Milsom SR; Endocrinology, Fertility Associates, Ascot Hospital, Auckland, New Zealand.; Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.; Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.; Pokaż więcej
Źródło :: The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2020 Jun; Vol. 60 (3), pp. 405-411. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Pregnancy Complications, Neoplastic*
Dopamine Agonists/*therapeutic use
Infertility/*drug therapy
Pituitary Neoplasms/*complications
Prolactinoma/*complications
Abortion, Spontaneous/epidemiology ; Adenoma ; Adolescent ; Adult ; Bromocriptine/therapeutic use ; Cabergoline/therapeutic use ; Cohort Studies ; Female ; Humans ; Lactation ; Postpartum Period ; Pregnancy ; Pregnancy Outcome/epidemiology ; Retrospective Studies ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.
Autorzy :: Tang C; Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, 210002, Nanjing, China.
Sun R; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, 200032, Shanghai, China.
Wen G; Tungwah Hospital of Sun Yat-Sen University, Dongguan, China.
Zhong C; School of Medicine, Nanjing Medical University, 104 Hanzhong Road, 210002, Nanjing, China.
Yang J; School of Medicine, Nanjing Medical University, 104 Hanzhong Road, 210002, Nanjing, China.
Zhu J; School of Medicine, Nanjing Medical University, 104 Hanzhong Road, 210002, Nanjing, China.
Cong Z; Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, 210002, Nanjing, China.
Luo X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, 200032, Shanghai, China. .
Ma C; Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, 210002, Nanjing, China. .; Pokaż więcej
Źródło :: Cell death & disease [Cell Death Dis] 2019 Apr 18; Vol. 10 (5), pp. 335. Date of Electronic Publication: 2019 Apr 18.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Apoptosis/*drug effects
Bromocriptine/*pharmacology
Cabergoline/*pharmacology
Signal Transduction/*drug effects
Amino Acid Chloromethyl Ketones/pharmacology ; Animals ; Bromocriptine/therapeutic use ; Cabergoline/therapeutic use ; Cell Line, Tumor ; Early Growth Response Protein 1/antagonists & inhibitors ; Early Growth Response Protein 1/genetics ; Early Growth Response Protein 1/metabolism ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Female ; Mice ; Mice, Nude ; Microtubule-Associated Proteins/metabolism ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/metabolism ; Pituitary Neoplasms/pathology ; Prolactinoma/drug therapy ; Prolactinoma/metabolism ; Prolactinoma/pathology ; Proto-Oncogene Proteins c-akt/metabolism ; RNA Interference ; RNA, Small Interfering/metabolism ; Rats ; TOR Serine-Threonine Kinases/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.
Autorzy :: Pottoo FH; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech., University of Kashmir, Srinagar, India. .
Tabassum N; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech., University of Kashmir, Srinagar, India. .
Javed MN; Department of Pharmaceutics, School of Pharmaceutical Sciences and Research, Jamia Hamdard, New Delhi, India.
Nigar S; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech., University of Kashmir, Srinagar, India.
Rasheed R; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech., University of Kashmir, Srinagar, India.
Khan A; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech., University of Kashmir, Srinagar, India.
Barkat MA; Department of Pharmacy, School of Medical and Allied Sciences, K.R. Mangalam University, Gurugram, India.
Alam MS; Department of Pharmacy, School of Medical and Allied Sciences, K.R. Mangalam University, Gurugram, India.
Maqbool A; Department of Zoology, Govt. College for Women, M. A. Road, Srinagar, India.
Ansari MA; Department of Epidemic Disease Research, Institute of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia.
Barreto GE; Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.; Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Santiago, Chile.
Ashraf GM; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Pokaż więcej
Źródło :: Molecular neurobiology [Mol Neurobiol] 2019 Feb; Vol. 56 (2), pp. 1233-1247. Date of Electronic Publication: 2018 Jun 07.
Typ publikacji :: Journal Article
MeSH Terms :: Anticonvulsants/*therapeutic use
Bromocriptine/*therapeutic use
Epilepsy, Temporal Lobe/*drug therapy
Fluoxetine/*therapeutic use
Raloxifene Hydrochloride/*therapeutic use
Status Epilepticus/*drug therapy
Animals ; Anticonvulsants/pharmacology ; Bromocriptine/pharmacology ; Disease Models, Animal ; Drug Synergism ; Drug Therapy, Combination ; Epilepsy, Temporal Lobe/chemically induced ; Epilepsy, Temporal Lobe/metabolism ; Female ; Fluoxetine/pharmacology ; Hippocampus/drug effects ; Hippocampus/metabolism ; Male ; Mice ; Neurons/drug effects ; Neurons/metabolism ; Oxidative Stress/drug effects ; Pilocarpine ; Raloxifene Hydrochloride/pharmacology ; Status Epilepticus/chemically induced ; Status Epilepticus/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.
Autorzy :: Palle S; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.
Neerati P; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.; Pokaż więcej
Źródło :: Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2018 Oct; Vol. 48 (10), pp. 1028-1036. Date of Electronic Publication: 2017 Nov 10.
Typ publikacji :: Journal Article
MeSH Terms :: Bromocriptine/*pharmacokinetics
Cytochrome P-450 CYP3A/*metabolism
Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics
Cytochrome P-450 CYP3A Inhibitors/*pharmacology
Intestines/*enzymology
Liver/*enzymology
Nanoparticles/*chemistry
Quercetin/*pharmacology
Administration, Oral ; Animals ; Biological Transport/drug effects ; Bromocriptine/administration & dosage ; Bromocriptine/blood ; Bromocriptine/pharmacology ; Calibration ; Cytochrome P-450 CYP3A Inhibitors/administration & dosage ; Cytochrome P-450 CYP3A Inhibitors/blood ; Male ; Microsomes/drug effects ; Microsomes/enzymology ; Nanoparticles/ultrastructure ; Permeability ; Rats, Wistar
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: [The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy].
Autorzy :: Kurbanov RD; Republican Specialized Scientific and Practical Medical Center for Cardiology of the Ministry of Health of the Republic of Uzbekistan (RSSPMCC), Tashkent.
Mirzarakhimova ST; Republican Specialized Scientific and Practical Medical Center for Cardiology of the Ministry of Health of the Republic of Uzbekistan (RSSPMCC), Tashkent.
Abdullaev TA; Republican Specialized Scientific and Practical Medical Center for Cardiology of the Ministry of Health of the Republic of Uzbekistan (RSSPMCC), Tashkent.
Tsoy IA; Republican Specialized Scientific and Practical Medical Center for Cardiology of the Ministry of Health of the Republic of Uzbekistan (RSSPMCC), Tashkent.; Pokaż więcej
Źródło :: Kardiologiia [Kardiologiia] 2020 Jul 07; Vol. 60 (6), pp. 984. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :: Journal Article
MeSH Terms :: Cardiomyopathies*/drug therapy
Bromocriptine/*therapeutic use
Humans ; Peripartum Period ; Quality of Life ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.
Autorzy :: Moore MC; Department of Metabolic Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Smith MS; Department of Metabolic Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Swift LL; Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Cincotta AH; VeroScience LLC, Tiverton, Rhode Island.
Ezrokhi M; VeroScience LLC, Tiverton, Rhode Island.
Cominos N; VeroScience LLC, Tiverton, Rhode Island.
Zhang Y; VeroScience LLC, Tiverton, Rhode Island.
Farmer B; Department of Metabolic Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Cherrington AD; Department of Metabolic Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.; Pokaż więcej
Źródło :: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2020 Jul 01; Vol. 319 (1), pp. E133-E145. Date of Electronic Publication: 2020 May 27.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Diet, High-Fat*
Blood Glucose/*drug effects
Bromocriptine/*pharmacology
Dopamine Agonists/*pharmacology
Glucose Intolerance/*metabolism
Liver/*drug effects
Animals ; Blood Glucose/metabolism ; Dogs ; Fatty Acids, Nonesterified/metabolism ; Glucagon/drug effects ; Glucagon/metabolism ; Glucose/metabolism ; Glucose Clamp Technique ; Glucose Tolerance Test ; Glycogen/metabolism ; Hepatic Veins ; Insulin/metabolism ; Lactic Acid/metabolism ; Liver/metabolism ; Portal Vein ; Somatostatin
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
Autorzy :: Michael Besser G; Medicine, St Bartholomew's Hospital, London, UK.
Pfeiffer RF; Neurology, Oregon Health & Science University, Portland, Oregon, USA.
Thorner MO; Medicine, University of Virginia, Charlottesville, Virginia, USA.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2018 Aug; Vol. 179 (2), pp. R69-R75. Date of Electronic Publication: 2018 May 11.
Typ publikacji :: Historical Article; Journal Article; Review
MeSH Terms :: Antiparkinson Agents/*therapeutic use
Bromocriptine/*therapeutic use
Dopamine Agonists/*therapeutic use
Drug Discovery/*history
Parkinson Disease/*drug therapy
Acromegaly/drug therapy ; Acromegaly/history ; Animals ; Anniversaries and Special Events ; Antiparkinson Agents/history ; Antiparkinson Agents/isolation & purification ; Antiparkinson Agents/poisoning ; Bromocriptine/isolation & purification ; Bromocriptine/metabolism ; Bromocriptine/poisoning ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/history ; Dopamine Agonists/history ; Dopamine Agonists/isolation & purification ; Dopamine Agonists/poisoning ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/history ; Ergotism/etiology ; Ergotism/history ; History, 20th Century ; Hormone Antagonists/adverse effects ; Hormone Antagonists/history ; Hormone Antagonists/therapeutic use ; Humans ; Hyperprolactinemia/drug therapy ; Hyperprolactinemia/history ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/history ; Hypoglycemic Agents/therapeutic use ; Parkinson Disease/history ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/history
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study.
Autorzy :: Budayr, Amer
Tan, Thida C.
Lo, Joan C.
Zaroff, Jonathan G.
Tabada, Grace H.
Yang, Jingrong
Go, Alan S.; Pokaż więcej
Źródło :: BMC Endocrine Disorders. 2/19/2020, Vol. 20 Issue 1, p1-9. 9p. 2 Charts.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
Autorzy :: Pottoo FH; Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O.BOX 1982, Dammam, 31441 Saudi Arabia. Electronic address: .
Tabassum N; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech, University of Kashmir, Srinagar, India. Electronic address: .
Javed MN; Department of Pharmaceutics, School of Pharmaceutical Sciences and Research, Jamia Hamdard University, New Delhi, India; School of Pharmaceutical Sciences, Apeejay Stya University, Gurugram, Haryana, India.
Nigar S; Department of Pharmaceutical Sciences, Faculty of Applied Sc. and Tech, University of Kashmir, Srinagar, India.
Sharma S; Department of Pharmacy, School of Medical and Allied Sciences, K.R.Mangalam University, Gurgaon, India.
Barkat MA; Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Al Jamiah, Hafr Al Batin 39524, Saudi Arabia.
Harshita; Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Al Jamiah, Hafr Al Batin 39524, Saudi Arabia.
Alam MS; Department of Pharmacy, School of Medical and Allied Sciences, K.R.Mangalam University, Gurgaon, India.
Ansari MA; Department of Epidemic Disease Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O.BOX 1982, Dammam, 31441 Saudi Arabia.
Barreto GE; Department of Biological Sciences, University of Limerick, Limerick, Ireland; Health Research Institute, University of Limerick, Ireland. Electronic address: .
Ashraf GM; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: .; Pokaż więcej
Źródło :: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2020 Apr 15; Vol. 146, pp. 105261. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji :: Journal Article
MeSH Terms :: Anticonvulsants/*therapeutic use
Electroshock/*adverse effects
Fluoxetine/*therapeutic use
Raloxifene Hydrochloride/*therapeutic use
Seizures/*prevention & control
Animals ; Bromocriptine/administration & dosage ; Bromocriptine/pharmacology ; Bromocriptine/therapeutic use ; Disease Models, Animal ; Drug Synergism ; Drug Therapy, Combination ; Fluoxetine/administration & dosage ; Fluoxetine/pharmacology ; Glutamic Acid/metabolism ; Hippocampus/drug effects ; Hippocampus/metabolism ; Mice ; Neuropeptide Y/metabolism ; Oxidative Stress/drug effects ; Raloxifene Hydrochloride/administration & dosage ; Raloxifene Hydrochloride/pharmacology ; Receptors, Dopamine/metabolism ; Receptors, Serotonin/metabolism ; Seizures/etiology ; Signal Transduction/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
Autorzy :: Sieweke JT; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Pfeffer TJ; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Berliner D; Department of Cardiology and Angiology, Hannover Medical School, Germany.
König T; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Hallbaum M; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Napp LC; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Tongers J; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Kühn C; Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Germany.
Schmitto JD; Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Germany.
Hilfiker-Kleiner D; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Schäfer A; Department of Cardiology and Angiology, Hannover Medical School, Germany.
Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Germany.; Pokaż więcej
Źródło :: European heart journal. Acute cardiovascular care [Eur Heart J Acute Cardiovasc Care] 2020 Mar; Vol. 9 (2), pp. 173-182. Date of Electronic Publication: 2018 May 24.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Cardiomyopathies/*etiology
Shock, Cardiogenic/*etiology
Shock, Cardiogenic/*therapy
Ventricular Function, Left/*drug effects
Adult ; Bromocriptine/therapeutic use ; Cardiomyopathies/diagnosis ; Cardiomyopathies/therapy ; Combined Modality Therapy ; Extracorporeal Membrane Oxygenation/adverse effects ; Female ; Heart Failure/therapy ; Hormone Antagonists/therapeutic use ; Humans ; Peripartum Period ; Pregnancy ; Pregnancy Complications, Cardiovascular/physiopathology ; Prospective Studies ; Shock, Cardiogenic/mortality ; Stroke Volume/physiology ; Survival Rate ; Treatment Outcome ; Ventricular Function, Left/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: The D2-family receptor agonist bromocriptine but, not nicotine, reverses NMDA receptor antagonist-induced working memory deficits in the radial arm maze in mice.
Autorzy :: MacQueen DA; Department of Psychology, University of North Carolina Wilmington, 601 S. College Road, Wilmington, NC 28403, United States. Electronic address: .
Young JW; Department of Psychiatry, School of Medicine, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA 92093-0804, United States; Research Service, VA San Diego Healthcare System, San Diego, CA, United States.; Pokaż więcej
Źródło :: Neurobiology of learning and memory [Neurobiol Learn Mem] 2020 Feb; Vol. 168, pp. 107159. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji :: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Bromocriptine/*administration & dosage
Maze Learning/*drug effects
Memory, Short-Term/*drug effects
Memory, Short-Term/*physiology
Nicotine/*administration & dosage
Receptors, Dopamine D2/*agonists
Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors
Animals ; Dizocilpine Maleate/administration & dosage ; Dopamine Agonists/administration & dosage ; Male ; Mice, Inbred C57BL
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Prolactinomas in pregnancy: considerations before conception and during pregnancy.
Autorzy :: Glezer A; Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clinicas, University of Sao Paulo Medical School, Rua Dr. Enéas de Carvalho Aguiar, no 155, 8° andar, bloco 3 (Endocrinologia), São Paulo, SP, 05403-000, Brazil.
Bronstein MD; Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clinicas, University of Sao Paulo Medical School, Rua Dr. Enéas de Carvalho Aguiar, no 155, 8° andar, bloco 3 (Endocrinologia), São Paulo, SP, 05403-000, Brazil. .; Pokaż więcej
Źródło :: Pituitary [Pituitary] 2020 Feb; Vol. 23 (1), pp. 65-69.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Bromocriptine/therapeutic use ; Female ; Humans ; Pregnancy
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bromocriptine"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język